Kohji Naora
Overview
Explore the profile of Kohji Naora including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karino S, Usuda H, Kanda S, Okamoto T, Niibayashi T, Yano T, et al.
Biochem Biophys Rep
. 2024 Nov;
40:101848.
PMID: 39498441
This study investigated whether a standard calorie diet that is high in glucose and deficient in dietary fibre (described as HGD [high glucose diet]) induces hepatic fat accumulation in mice....
2.
Onita T, Nakamura K, Nishikawa G, Ishihara N, Tamaki H, Yano T, et al.
J Clin Pharmacol
. 2024 Aug;
PMID: 39183683
This study aimed to develop a prostatic pharmacokinetic model of ceftazidime and suggest more effective dosing strategy for the bacterial prostatitis, based on a site-specific pharmacokinetic and pharmacodynamic perspective. Subjects...
3.
Onita T, Ikawa K, Ishihara N, Tamaki H, Yano T, Naora K, et al.
Antibiotics (Basel)
. 2023 Feb;
12(2).
PMID: 36830214
This study aimed to assess the dosing regimens of ampicillin/sulbactam for pneumonia based on pulmonary pharmacokinetic (PK)/pharmacodynamic (PD) target attainment. Using the literature data, we developed pulmonary PK models and...
4.
Onita T, Ishihara N, Ikebuchi A, Yano T, Nishimura N, Tamaki H, et al.
J Clin Pharm Ther
. 2022 Jul;
47(12):2041-2048.
PMID: 35893441
What Is Known And Objective: Linezolid (LZD) may cause thrombocytopenia, which can result in discontinuation of treatment. In this study, the blood LZD trough concentration was estimated based on population...
5.
Pharmacodynamic Evaluation of Ampicillin-sulbactam in Pediatric Patients Using Plasma and Urine Data
Onita T, Ikawa K, Ishihara N, Tamaki H, Yano T, Naora K, et al.
Pediatr Infect Dis J
. 2022 Feb;
41(5):411-416.
PMID: 35195566
Background: We aimed to develop population pharmacokinetic (PK) models of ampicillin and sulbactam using pooled data analysis and to optimize dosing regimens of ampicillin-sulbactam (combination ratio of 2:1) in pediatric...
6.
Tobita H, Yazaki T, Kataoka M, Kotani S, Oka A, Mishiro T, et al.
J Clin Biochem Nutr
. 2021 Apr;
68(2):173-180.
PMID: 33879970
There are no reports regarding the efficacy of sodium-glucose cotransporter 2 inhibitor (SGLT2i) and dipeptidyl peptidase 4 inhibitor (DPP4i) administrations in nonalcoholic fatty liver disease (NAFLD) patients without type 2...
7.
Onita T, Ishihara N, Yano T, Nishimura N, Tamaki H, Ikawa K, et al.
Yakugaku Zasshi
. 2021 Mar;
141(3):441-445.
PMID: 33642514
Herein, we describe a case of an elderly patient with muscular dystrophy for whom control of the plasma vancomycin (VCM) concentration proved difficult when he developed a catheter-related bloodstream infection....
8.
Onita T, Ikawa K, Nakamura K, Nishikawa G, Kobayashi I, Ishihara N, et al.
J Clin Pharmacol
. 2020 Dec;
61(6):820-831.
PMID: 33314138
This study aims to define the penetration of ampicillin and sulbactam into prostate tissue, develop a prostatic pharmacokinetic model of each drug, and assess the appropriateness of ampicillin-sulbactam regimens for...
9.
Ishihara N, Nishimura N, Ikawa K, Karino F, Miura K, Tamaki H, et al.
Antibiotics (Basel)
. 2020 Mar;
9(3).
PMID: 32155905
The aim of this study was to develop a population pharmacokinetic model for piperacillin (PIPC)/tazobactam (TAZ) in late elderly patients with pneumonia and to optimize the administration planning by applying...
10.
Chen Z, Nishimura N, Okamoto T, Wada K, Naora K
Biomed Res Int
. 2019 Dec;
2019:1269532.
PMID: 31871929
Multidrug resistance is the main obstacle to current chemotherapies. In this study, we evaluated the reversing effect of matrine, the principal alkaloid derived from , on chemoresistant leukemia K562/ADR cells....